Skip to content
Research Article Open access CC BY 4.0

A Note on the Current Status of the Trans-ungual Delivery of Poorly Soluble Drugs at a Glance: Formulation Perspective

Srinivas Bhairy, Alfiha Momin, Mugdha Pednekar, Devendra Madan, Ashraf Shaikh, Rahul Bankar, Subrahmanyam Pitchika

Asian Journal of Research in Infectious Diseases · pp. 1–21 · Published 21 Feb 2023

10.9734/ajrid/2023/v12i3244

Abstract

The Trans ungual drug delivery (TUDD) system involves the delivery of drugs through the hard keratinized nail plate. Topical treatment is ideal for treating nail diseases because it has localized effects, resulting in fewer systemic side effects and perhaps better adherence. Conventional formulations have failed to promote nail adhesion and medication absorption due to the nail's highly keratinized hydrophilic nature, which obstructs drug absorption. Systemic therapy has several side effects and a high rate of recurrence, whereas surgery is painful and invasive. As a result, there is a definite need to design an efficient TUDD system that allows antifungals to penetrate the nail and reach the infection site at a sufficient concentration and for a longer period of action to eliminate the infection. The system also avoids the oral toxicity of drugs. Several techniques, including physical, chemical, and mechanical, are employed to increase medication penetration over the nail plate. To increase nail adherence, therapeutic action, and bioavailability, several innovative formulation techniques are being researched, including the use of penetration enhancers in traditional dosage forms (gel, solution), novel dosage forms such as films, nail lacquer, and nanotechnology.

Trans ungual drug delivery human nail anti-fungal permeation novel formulations nanotechnology bioavailability

References (115)

  1. 1 Ultrasound mediated transdermal drug delivery [DOI]
  2. 2 Drug delivery to the nail following topical application [DOI]
  3. 3 Microemulsion-Based Gel of Terbinafine for the Treatment of Onychomycosis: Optimization of Formulation Using D-Optimal Design [DOI]
  4. 4 Enhancing the nail permeability of topically applied drugs [DOI]
  5. 5 In-vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Prediction of the Penetration Rate of Antimycotics through the Nail Plate and their Efficacy [DOI]
  6. 6 Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis [DOI]
  7. 7 In-vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Influence of the Partition Coefficient Octanol/Water and the Water Solubility of Drugs on their Permeability and Maximum Flux [DOI]
  8. 8 In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs [DOI]
  9. 9 Physical enhancement of dermatologic drug delivery: Iontophoresis and phonophoresis [DOI]
  10. 10 Photodynamic therapy of onychomycosis caused by Trichophyton rubrum [DOI]
  11. 11 Iontophoretic Drug Delivery across Human Nail [DOI]
  12. 12 Insights into drug delivery across the nail plate barrier [DOI]
  13. 13 Effect of hydration on the permeation of ketoconazole through human nail plate in vitro [DOI]
  14. 14 Transungual drug delivery: Current status [DOI]
  15. 15 Review of antifungal therapy and the severity index for assessing onychomycosis: Part I [DOI]
  16. 16 Structural characteristics and permeability properties of the human nail : A review
  17. 17 Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis [DOI]
  18. 18 Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement [DOI]
  19. 19 Investigation of different formulations for drug delivery through the nail plate [DOI]
  20. 20 Physicochemical characterization of the human nail: solvent effects on the permeation of homologous alcohols [DOI]
  21. 21 Management of Onychomycoses [DOI]
  22. 22 Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine [DOI]
  23. 23 Determination of diallyl thiosulfinate (allicin) in garlic (Allium sativum L.) by high-performance liquid chromatography with a post-column photochemical reactor [DOI]
  24. 24 Investigation of nail permeation enhancement by chemical modification using water as a probe [DOI]
  25. 25 Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity [DOI]
  26. 26 Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: Application to the delivery of triamcinolone acetonide and ciclopirox olamine [DOI]
  27. 27 Permeation of ciclopirox across porcine hoof membrane: effect of pressure sensitive adhesives and vehicles [DOI]
  28. 28 TranScreen-N™: Method for rapid screening of trans-ungual drug delivery enhancers [DOI]
  29. 29 An Ex Vivo Toe Model Used to Assess Applicators for the Iontophoretic Ungual Delivery of Terbinafine [DOI]
  30. 30 Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro [DOI]
  31. 31 A study on the effect of inorganic salts in transungual drug delivery of terbinafine [DOI]
  32. 32 Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies [DOI]
  33. 33 Controlled nail trephination for subungual hematoma [DOI]
  34. 34 Matrix based system of isotretinoin as nail lacquer to enhance transungal delivery across human nail plate [DOI]
  35. 35 Transungual delivery of ketoconazole using novel lacquer formulation [DOI]
  36. 36 Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis [DOI]
  37. 37 Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial [DOI]
  38. 38 Allium chemistry: identification of organosulfur compounds in ramp (allium tricoccum) homogenates fn1 fn1Dedicated with best wishes to Professor G. H. Neil Towers on the occasion of his 75th birthday. [DOI]
  39. 39 Penetration of the human nail plate: the effects of vehicle pH on the permeation of miconazole [DOI]
  40. 40 The human nail: structure, growth and pathological changes.
  41. 41 Carbon Dioxide Laser Use for Certain Diseases of the Toenails [DOI]
  42. 42 Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents [DOI]
  43. 43 Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects [DOI]
  44. 44 1st Meeting on Topical Drug Delivery to the Nail [DOI]
  45. 45 Comparison of the Antifungal Efficacy of Terbinafine Hydrochloride and Ciclopirox Olamine Containing Formulations against the Dermatophyte Trichophyton rubrum in an Infected Nail Plate Model [DOI]
  46. 46 Treatment of onychomycosis with nail avulsion and topical ketoconazole [DOI]
  47. 47 Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro [DOI]
  48. 48 Effect of pressure sensitive adhesive and vehicles on permeation of terbinafine across porcine hoof membrane [DOI]
  49. 49 Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success [DOI]
  50. 50 Nail Penetration of Sertaconazole with a Sertaconazole-Containing Nail Patch Formulation [DOI]
  51. 51 Characterization and use of essential oil from Thymus vulgaris against Botrytis cinerea and Rhizopus stolonifer in strawberry fruits [DOI]
  52. 52 Similarities and Specificities of Fungal Keratinolytic Proteases: Comparison of Keratinases of Paecilomyces marquandii and Doratomyces microsporus to Some Known Proteases [DOI]
  53. 53 Ross and Wilson Anatomy and Physiology in Health and Illness
  54. 54 Epidemiology and clinical classification of onychomycosis [DOI]
  55. 55 Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis [DOI]
  56. 56 Onychomycosis and Other Superficial Fungal Infections of the Foot in the Elderly: A Pan-European Survey [DOI]
  57. 57 Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation [DOI]
  58. 58 Ungual and Transungual drug delivery [DOI]
  59. 59 New Polyurethane Nail Lacquers for the Delivery of Terbinafine: Formulation and Antifungal Activity Evaluation [DOI]
  60. 60 A comparative study of the physicochemical properties of human keratinized tissues [DOI]
  61. 61 Drug Permeation through the Three Layers of the Human Nail Plate [DOI]
  62. 62 Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum [DOI]
  63. 63 Nail Swelling as a Pre-formulation Screen for the Selection and Optimisation of Ungual Penetration Enhancers [DOI]
  64. 64 Onychomycosis: therapeutic update [DOI]
  65. 65 An investigation into keratinolytic enzymes to enhance ungual drug delivery [DOI]
  66. 66 In Vitro Transungual Permeation of Ciclopirox from a Hydroxypropyl Chitosan-Based, Water-Soluble Nail Lacquer [DOI]
  67. 67 Influence of human nail etching for the assessment of topical onychomycosis therapies [DOI]
  68. 68 Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine [DOI]
  69. 69 Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis [DOI]
  70. 70 The effectiveness of lasers in the treatment of onychomycosis: a systematic review [DOI]
  71. 71 Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems [DOI]
  72. 72 Effect of Polyethylene Glycols on the Trans-Ungual Delivery of Terbinafine [DOI]
  73. 73 Influence of Tartaric Acid on the Bioadhesion and Mechanical Properties of Hot-Melt Extruded Hydroxypropyl Cellulose Films for the Human Nail [DOI]
  74. 74 Water diffusivity in human nail plate [DOI]
  75. 75 Effect of Film-Forming Polymers on Release of Naftifine Hydrochloride from Nail Lacquers [DOI]
  76. 76 Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis [DOI]
  77. 77 Transungual Gel of Terbinafine Hydrochloride for the Management of Onychomycosis: Formulation, Optimization, and Evaluation [DOI]
  78. 78 Enhancing Effect of N-Acetyl-L-cysteine or 2-Mercaptoethanol on the in Vitro Permeation of 5-Fluorouracil or Tolnaftate through the Human Nail Plate. [DOI]
  79. 79 Iontophoretic permselective property of human nail [DOI]
  80. 80 Transungual Iontophoretic Transport of Polar Neutral and Positively Charged Model Permeants: Effects of Electrophoresis and Electroosmosis [DOI]
  81. 81 The Effect of Keratolytic Agents on the Permeability of Three Imidazole Antimycotic Drugs Through the Human Nail [DOI]
  82. 82 Nail morphology studies as assessments for onychomycosis treatment modalities [DOI]
  83. 83 Bilayered Nail Lacquer of Terbinafine Hydrochloride for Treatment of Onychomycosis [DOI]
  84. 84 Hydroxypropyl-β-cyclodextrin: A Novel Transungual Permeation Enhancer for Development of Topical Drug Delivery System for Onychomycosis [DOI]
  85. 85 Transungual drug delivery: An overview.
  86. 86 Effects of Ionic Strength on Passive and Iontophoretic Transport of Cationic Permeant Across Human Nail [DOI]
  87. 87 A Novel Apremilast Nail Lacquer Formulation for the Treatment of Nail Psoriasis [DOI]
  88. 88 Controlled-release injectable containing Terbinafine/PLGA microspheres for Onychomycosis Treatment [DOI]
  89. 89 A platform for predicting and enhancing model drug delivery across the human nail plate [DOI]
  90. 90 A first order experimental design to assess soluble proteins released by a new keratinase from Doratomyces microsporus on human substrates [DOI]
  91. 91 Establishment of a Novel Model of Onychomycosis in Rabbits for Evaluation of Antifungal Agents [DOI]
  92. 92 Development of ciclopirox nail lacquer with enhanced permeation and retention [DOI]
  93. 93 Antifungal potential of tolnaftate against Candida albicans in the treatment of onychomycosis: development of nail lacquer and ex vivo characterization [DOI]
  94. 94 UNGUAL DRUG DELIVERY SYSTEM OF KETOCONAZOLE NAIL LACQUER
  95. 95 In vitro human nail penetration and kinetics of panthenol [DOI]
  96. 96 TRANSUNGUAL DRUG DELIVERY SYSTEM: A REVIEW
  97. 97 Equilibrium Constants of the Reactions of Sulfite with Cystine and with Dithiodiglycolic Acid [DOI]
  98. 98 EXPLORING THE PHARMACOGNOSTIC CHARACTERISTICS AND ANTIMICROBIAL POTENTIAL OF LEAVES OF URENA LOBATA LINN. [DOI]
  99. 99 DRUG DELIVERY ACROSS HUMAN NAIL: A NEWER APPROACH
  100. 100 Onychomycosis [DOI]
  101. 101 Nail abrasion [DOI]
  102. 102 In-situ gels and nail lacquers as potential delivery systems for treatment of onychomycosis. A comparative study [DOI]
  103. 103 Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration [DOI]
  104. 104 Influence of a Combination of Chemical Enhancers and Iontophoresis on In Vitro Transungual Permeation of Nystatin [DOI]
  105. 105 Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis [DOI]
  106. 106 On the structure of the normal nail [DOI]
  107. 107 Nail drug delivery system a review [DOI]
  108. 108 Preungual drug delivery systems of Terbinafine Hydrochloride Nail Lacquer [DOI]
  109. 109 Smart ungual biopenetrant from the roots of Beta vulgaris
  110. 110 A randomized, double-blind, placebo-controlled, pilot study of 1% terbinafine cream applied twice daily and delivered via nail plate microporation for the treatment of subungual toenail onychomycosis [DOI]
  111. 111 Inspection of a novel penetration enhancer for transungual drug delivery system: Pelargonium hortorum
  112. 112 Treatment of distal onychomycosis with avulsion and topical antifungal agents under occlusion [DOI]
  113. 113 Ciclopirox (Penlac) nail lacquer for onychomycosis.
  114. 114 Principles of Anatomy and Physiology [DOI]
  115. 115 Formulation and Evaluation of a Medicated Nail Lacquer for the Treatment of Onychomycosis

Cited by 4

A recent review on transungual drug delivery system

Simran Kaur, Mohit Kumar, Amit Bhatia · Journal of Dispersion Science and Technology · 2024

Therapeutic treatment strategies for the management of onychomycosis: a patent perspective

Snigdha Chakraborty, Sanshita, Inderbir Singh · Expert Opinion on Therapeutic Patents · 2023

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

55

Page views

0

PDF downloads

35

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.